Andreas Chott
Ottakring, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Paraneoplastic anti-SRP antibody positive immune-mediated necrotizing myopathy in a young female associated with lymphoma.
Journal: Journal of neuromuscular diseases
Published: April 23, 2025
Multifactorial White Matter Damage in the Acute Phase and Pre-Existing Conditions May Drive Cognitive Dysfunction after SARS-CoV-2 Infection: Neuropathology-Based Evidence.
Journal: Viruses
Published: February 20, 2023
Rare differential diagnosis in bilateral gonalgia
Journal: Pathologie (Heidelberg, Germany)
Published: July 05, 2022
Thyroid MALT lymphoma: self-harm to gain potential T-cell help.
Journal: Leukemia
Published: January 31, 2021
Death of unknown cause? Post-mortem diagnosis of fulminant course of an EBV-associated secondary hemophagocytic lymphohistiocytosis.
Journal: Memo
Published: January 14, 2021
Multiple cerebral lesions in a patient with refractory celiac disease: A case report.
Journal: World journal of gastroenterology
Published: August 24, 2020
Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease.
Journal: Blood advances
Published: July 14, 2020
High activation of STAT5A drives peripheral T-cell lymphoma and leukemia.
Journal: Haematologica
Published: January 18, 2019
SYK expression in monomorphic epitheliotropic intestinal T-cell lymphoma.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 28, 2017
AL Amyloidoma of the Skin/Subcutis: Cutaneous Amyloidosis, Plasma Cell Dyscrasia or a Manifestation of Primary Cutaneous Marginal Zone Lymphoma?
Journal: The American journal of surgical pathology
Published: May 16, 2017
Case report: impressive response to pembrolizumab in a patient with mismatch-repair deficient metastasized colorectal cancer and bulky disease.
Journal: ESMO open
Published: June 13, 2016
Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas: A Retrospective Cohort Study.
Journal: Medicine
Published: December 31, 2015
Last Updated: 09/26/2026